Two case reports of a malignant germ cell tumor of ovary and a granulosa cell tumor: interest of tumoral immunochemistry in the identification and management

In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23-year old woman and the second case was a bilateral undifferentiated granulosa cell tumor in a 71-year old woman. The aim of these reports is to illustrate the interest of the immun...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 4; p. 97
Main Authors Bouquet de Jolinière, J, Ben Ali, N, Fadhlaoui, A, Dubuisson, J B, Guillou, L, Sutter, A, Betticher, D, Hoogewoud, H M, Feki, A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 01.01.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23-year old woman and the second case was a bilateral undifferentiated granulosa cell tumor in a 71-year old woman. The aim of these reports is to illustrate the interest of the immunohistochemical analysis to define the correct diagnosis, to better classify these ovarian tumors and improve their management. In this study, we report two cases. The first case concerns a 23-year old woman (A) with a mixed germ cell tumor of the right ovary [dysgerminoma (75%), yolk sac tumor (20%), and a mature teratoma (5%)], and the second case concerns a 71-year old woman (B) with a bilateral non-differentiated and necrotic granulosa cell tumor of both ovaries. The staging system was used according to both the classifications: International Federation of Gynaecology and Obstetrics 1987 for ovarian cancer and TNM code 2009. The immunostaining establishes the malignancy and the immunochemistry contributes to confirm effectively the right diagnosis (Tables 2 and 3). An immunohistochemical analysis is mandatory for the choice of chemotherapy to obtain a better response of the disease and improve the survival prognosis. The efficiency of the chemotherapy authorizes a conservative surgery including a unilateral salpingo-oophorectomy preserving fertility (A). Concerning the non-dysgerminoma tumor (B), and after a surgical staging and debulking, chemotherapy was recommended. The type of tumor and its histological feature conditioned the choice of treatment. The benefit of the immunohistological analysis in this case allowed the right adjuvant treatment.
AbstractList Objective: In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23-year old woman and the second case was a bilateral undifferentiated granulosa cell tumor in a 71-year old woman. The aim of these reports is to illustrate the interest of the immunohistochemical analysis to define the correct diagnosis, to better classify these ovarian tumors and improve their management. Methods: In this study, we report two cases. The first case concerns a 23-year old woman (A) with a mixed germ cell tumor of the right ovary [dysgerminoma (75%), yolk sac tumor (20%), and a mature teratoma (5%)], and the second case concerns a 71-year old woman (B) with a bilateral non-differentiated and necrotic granulosa cell tumor of both ovaries. The staging system was used according to both the classifications: International Federation of Gynaecology and Obstetrics 1987 for ovarian cancer and TNM code 2009. Results: The immunostaining establishes the malignancy and the immunochemistry contributes to confirm effectively the right diagnosis (Tables 2 and 3 ). Conclusion: An immunohistochemical analysis is mandatory for the choice of chemotherapy to obtain a better response of the disease and improve the survival prognosis. The efficiency of the chemotherapy authorizes a conservative surgery including a unilateral salpingo-oophorectomy preserving fertility (A). Concerning the non-dysgerminoma tumor (B), and after a surgical staging and debulking, chemotherapy was recommended. The type of tumor and its histological feature conditioned the choice of treatment. The benefit of the immunohistological analysis in this case allowed the right adjuvant treatment.
In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23-year old woman and the second case was a bilateral undifferentiated granulosa cell tumor in a 71-year old woman. The aim of these reports is to illustrate the interest of the immunohistochemical analysis to define the correct diagnosis, to better classify these ovarian tumors and improve their management. In this study, we report two cases. The first case concerns a 23-year old woman (A) with a mixed germ cell tumor of the right ovary [dysgerminoma (75%), yolk sac tumor (20%), and a mature teratoma (5%)], and the second case concerns a 71-year old woman (B) with a bilateral non-differentiated and necrotic granulosa cell tumor of both ovaries. The staging system was used according to both the classifications: International Federation of Gynaecology and Obstetrics 1987 for ovarian cancer and TNM code 2009. The immunostaining establishes the malignancy and the immunochemistry contributes to confirm effectively the right diagnosis (Tables 2 and 3). An immunohistochemical analysis is mandatory for the choice of chemotherapy to obtain a better response of the disease and improve the survival prognosis. The efficiency of the chemotherapy authorizes a conservative surgery including a unilateral salpingo-oophorectomy preserving fertility (A). Concerning the non-dysgerminoma tumor (B), and after a surgical staging and debulking, chemotherapy was recommended. The type of tumor and its histological feature conditioned the choice of treatment. The benefit of the immunohistological analysis in this case allowed the right adjuvant treatment.
Author Fadhlaoui, A
Feki, A
Hoogewoud, H M
Ben Ali, N
Betticher, D
Guillou, L
Bouquet de Jolinière, J
Sutter, A
Dubuisson, J B
AuthorAffiliation 1 Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
4 Department of Radiology, Hôpital Fribourgeois , Fribourg , Switzerland
2 Argot Laboratory Lausanne, Department of Pathology and Cytology , Lausanne , Switzerland
3 Department of Oncology, Hôpital Fribourgeois , Fribourg , Switzerland
AuthorAffiliation_xml – name: 3 Department of Oncology, Hôpital Fribourgeois , Fribourg , Switzerland
– name: 2 Argot Laboratory Lausanne, Department of Pathology and Cytology , Lausanne , Switzerland
– name: 1 Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
– name: 4 Department of Radiology, Hôpital Fribourgeois , Fribourg , Switzerland
Author_xml – sequence: 1
  givenname: J
  surname: Bouquet de Jolinière
  fullname: Bouquet de Jolinière, J
  organization: Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
– sequence: 2
  givenname: N
  surname: Ben Ali
  fullname: Ben Ali, N
  organization: Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
– sequence: 3
  givenname: A
  surname: Fadhlaoui
  fullname: Fadhlaoui, A
  organization: Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
– sequence: 4
  givenname: J B
  surname: Dubuisson
  fullname: Dubuisson, J B
  organization: Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
– sequence: 5
  givenname: L
  surname: Guillou
  fullname: Guillou, L
  organization: Argot Laboratory Lausanne, Department of Pathology and Cytology , Lausanne , Switzerland
– sequence: 6
  givenname: A
  surname: Sutter
  fullname: Sutter, A
  organization: Argot Laboratory Lausanne, Department of Pathology and Cytology , Lausanne , Switzerland
– sequence: 7
  givenname: D
  surname: Betticher
  fullname: Betticher, D
  organization: Department of Oncology, Hôpital Fribourgeois , Fribourg , Switzerland
– sequence: 8
  givenname: H M
  surname: Hoogewoud
  fullname: Hoogewoud, H M
  organization: Department of Radiology, Hôpital Fribourgeois , Fribourg , Switzerland
– sequence: 9
  givenname: A
  surname: Feki
  fullname: Feki, A
  organization: Department of Obstetrics and Gynecology, Hôpital Fribourgeois , Fribourg , Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24982844$$D View this record in MEDLINE/PubMed
BookMark eNpVkd1qGzEQhUVJaVLX17kLegE7Wv2sd3tRCCH9AUNvXOidmGhn1woryUhyQh4m7xqt3QT3SmLmO2dmOJ_JmQ8eCbms2FKIpr3ugzdLziq5ZIy1qw_kgnMhF60Uf89O_udkntJDQVitWMXEJ3LOZdvwRsoL8rJ5CtRAQhpxF2JONPQUqIPRDh58pgNGRw2OI817F-LUDo8Qnyn4roBDBL8fQ4IT5iu1PmPElCf6UIKRWuf2PpgtOpty0VtP8xap7dBn21sD2QZ_cHXgYUBX6l_Ixx7GhPN_74z8-X63uf25WP_-8ev2Zr0wohV5oapymlGrmoNAIRkIteoYGKj7plOcN4Uykhus27qUuDK1kfcrYAp505tKzMi3o-9uf--wM2V0WVnvonXlVB3A6v873m71EB61ZEo1ShWD66OBiSGliP27tmJ6CktPYekpLH0IqyiuTke-82_RiFdxUZct
CitedBy_id crossref_primary_10_7759_cureus_24497
crossref_primary_10_18231_j_ijpo_2021_084
Cites_doi 10.1016/j.jpedsurg.2003.11.027
10.1002/pbc.20233
10.1002/1097-0142(196708)20:81301::AID-CNCR28202008143.0.CO;2-4
10.1002/1097-0142(19850715)56:2243::AID-CNCR28205602063.0.CO;2-T
10.1007/978-1-4613-9232-3_13
10.1016/j.rigp.2005.09.001
10.1200/JCO.1994.12.4.701
10.1038/bjc.1997.136
10.1097/01.AOG.0000216004.22588.ce
10.1200/JCO.1997.15.2.620
10.1016/j.ygyno.2011.01.003
10.1002/pbc.20633
10.1006/gyno.1998.5047
10.1002/1097-0142(19940401)73:71980::AID-CNCR28207307323.0.CO;2-9
ContentType Journal Article
Copyright Copyright © 2014 Bouquet de Jolinière, Ben Ali, Fadhlaoui, Dubuisson, Guillou, Sutter, Betticher, Hoogewoud and Feki. 2014
Copyright_xml – notice: Copyright © 2014 Bouquet de Jolinière, Ben Ali, Fadhlaoui, Dubuisson, Guillou, Sutter, Betticher, Hoogewoud and Feki. 2014
DBID NPM
AAYXX
CITATION
5PM
DOI 10.3389/fonc.2014.00097
DatabaseName PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
DatabaseTitleList
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
ExternalDocumentID 10_3389_fonc_2014_00097
24982844
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c393t-51065c5762a3e340a357d0aca6f8d5228393c42ce6966f825c6c4b7a05e28fc13
IEDL.DBID RPM
ISSN 2234-943X
IngestDate Tue Sep 17 21:07:26 EDT 2024
Fri Aug 23 03:42:24 EDT 2024
Sat Sep 28 08:06:40 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords ovarian cell tumor
germ cell tumors
dysgerminoma
immunohistochemistry
yolk sac
teratoma
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c393t-51065c5762a3e340a357d0aca6f8d5228393c42ce6966f825c6c4b7a05e28fc13
Notes Reviewed by: Min-Han Tan, Institute of Bioengineering and Nanotechnology, Singapore; Nicholas Glenn Cost, Cincinnati Children’s Hospital Medical Center, USA
This article was submitted to Genitourinary Oncology, a section of the journal Frontiers in Oncology.
Edited by: Ulka N. Vaishampayan, Wayne State University, USA
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055855/
PMID 24982844
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055855
crossref_primary_10_3389_fonc_2014_00097
pubmed_primary_24982844
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in oncology
PublicationTitleAlternate Front Oncol
PublicationYear 2014
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References 9053485 - J Clin Oncol. 1997 Feb;15(2):620-4
16206211 - Pediatr Blood Cancer. 2006 Apr;46(4):459-64
15490488 - Pediatr Blood Cancer. 2005 Feb;44(2):167-73
7530680 - Gynecol Oncol. 1994 Dec;55(3 Pt 2):S62-72
9043039 - Br J Cancer. 1997;75(5):767-70
16648414 - Obstet Gynecol. 2006 May;107(5):1075-85
12576247 - Obstet Gynecol. 2003 Feb;101(2):251-7
15017564 - J Pediatr Surg. 2004 Mar;39(3):424-9; discussion 424-9
10636515 - Obstet Gynecol. 2000 Jan;95(1):128-33
4291636 - Cancer. 1967 Aug;20(8):1301-10
9698477 - Gynecol Oncol. 1998 Jul;70(1):70-4
2988740 - Cancer. 1985 Jul 15;56(2):243-8
21256579 - Gynecol Oncol. 2011 May 1;121(2):285-9
7512129 - J Clin Oncol. 1994 Apr;12(4):701-6
8137225 - Cancer. 1994 Apr 1;73(7):1980-3
Dark (B6) 1997; 15
Mandel (B4) 1994; 73
Slayton (B11) 1985; 56
Barber (B1) 1993
Dimopoulos (B14) 1998; 70
De Backer (B8) 2006; 46
Bailey (B2) 2005; 5
Smith (B13) 2006; 107
Weinberg (B10) 2011; 121
Teter (B3) 1967; 20
Schultz (B7) 2005; 44
Tangir (B9) 2003; 101
Williams (B12) 1994; 12
Billmire (B15) 2004; 39
Albrektsen (B5) 1997; 75
References_xml – volume: 39
  start-page: 424
  year: 2004
  ident: B15
  article-title: Outcome and staging in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study
  publication-title: J Pediatr Surg
  doi: 10.1016/j.jpedsurg.2003.11.027
  contributor:
    fullname: Billmire
– volume: 44
  start-page: 167
  year: 2005
  ident: B7
  article-title: Pediatric ovarian tumors: a review of 67 cases
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.20233
  contributor:
    fullname: Schultz
– volume: 20
  start-page: 1301
  year: 1967
  ident: B3
  article-title: Occurrence of tumors in dysgenetic gonads
  publication-title: Cancer
  doi: 10.1002/1097-0142(196708)20:81301::AID-CNCR28202008143.0.CO;2-4
  contributor:
    fullname: Teter
– volume: 101
  start-page: 2
  year: 2003
  ident: B9
  article-title: Ovarian germ cell malignancies
  publication-title: Obstet Gynecol
  contributor:
    fullname: Tangir
– volume: 56
  start-page: 243
  year: 1985
  ident: B11
  article-title: Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report)
  publication-title: Cancer
  doi: 10.1002/1097-0142(19850715)56:2243::AID-CNCR28205602063.0.CO;2-T
  contributor:
    fullname: Slayton
– volume-title: Ovarian Carcinoma-Aetiology, Diagnosis and Treatment
  year: 1993
  ident: B1
  article-title: Managing ovarian tumors of childhood and adolescence
  doi: 10.1007/978-1-4613-9232-3_13
  contributor:
    fullname: Barber
– volume: 5
  start-page: 201
  year: 2005
  ident: B2
  article-title: Management of germ cell tumors of the ovary
  publication-title: Rev Gynaecol Pract
  doi: 10.1016/j.rigp.2005.09.001
  contributor:
    fullname: Bailey
– volume: 12
  start-page: 701
  year: 1994
  ident: B12
  article-title: Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1994.12.4.701
  contributor:
    fullname: Williams
– volume: 75
  start-page: 767
  year: 1997
  ident: B5
  article-title: Full term pregnancy and incidence of ovarian cancer of stromal and germ cell origin: a Norwegian prospective study
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1997.136
  contributor:
    fullname: Albrektsen
– volume: 107
  start-page: 1075
  year: 2006
  ident: B13
  article-title: Incidence and survival rates for female malignant germ cell tumors
  publication-title: Obstet Gynecol
  doi: 10.1097/01.AOG.0000216004.22588.ce
  contributor:
    fullname: Smith
– volume: 15
  start-page: 620
  issue: 2
  year: 1997
  ident: B6
  article-title: Surveillance policy for stage 1 ovarian germ cell tumors
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1997.15.2.620
  contributor:
    fullname: Dark
– volume: 121
  start-page: 285
  year: 2011
  ident: B10
  article-title: Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2011.01.003
  contributor:
    fullname: Weinberg
– volume: 46
  start-page: 459
  year: 2006
  ident: B8
  article-title: Ovarian germ cell tumors in children: a clinical study of 66 patients
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.20633
  contributor:
    fullname: De Backer
– volume: 70
  start-page: 70
  year: 1998
  ident: B14
  article-title: Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study
  publication-title: Gynecol Oncol
  doi: 10.1006/gyno.1998.5047
  contributor:
    fullname: Dimopoulos
– volume: 73
  start-page: 1980
  year: 1994
  ident: B4
  article-title: Familial clustering of malignant germ cell tumors and Langerhans histiocytosis
  publication-title: Cancer
  doi: 10.1002/1097-0142(19940401)73:71980::AID-CNCR28207307323.0.CO;2-9
  contributor:
    fullname: Mandel
SSID ssj0000650103
Score 2.0445845
Snippet In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23-year old woman and the second case was...
Objective: In this article, we present two case reports. The first case was a malignant germ cell tumor of the right ovary in a 23-year old woman and the...
SourceID pubmedcentral
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 97
SubjectTerms Oncology
SummonAdditionalLinks – databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELWgSIgLYqds8oEDl0Aa20mDhBCqKItUuLRSb5Ht2FCpJNCF5WP4V2biUFqpB46JR07kF_vNc8YzhBxrZlgEYHtWaBAoSitP1UG4WiAjw2Kh_BTPO7cewtsOv--K7l85oHIAh3OlHdaT6gz6p59vX5cw4S9QcQLfntk8w2SENcyD7cfRIlkKOMh0jOMrfX23LAusaYDF5gLGvZizrkv1M6-PGZaaUNNs2OQUDzXXyGrpQNIrh_g6WTDZBllulb_IN8l3-yOnDeAm6nzrIc0tlbQF_vYTBr3QG1iLacP0-7Q9fskH2Pz4LgdfVGYpGN4AeY37-VBO2ZzTYuMQCASti1vwCnd4tAQLbrmKcbSXUfAmqTv6a8u9wKLXvxibLdJpXrcbt15Zg8HTLGYjD6ZsKDSIkkACqtyXTESpL7UMbT0VmDsnZpoH2oSgmwBgoUPNVSR9YYK61TW2TSpZnpldQkVNypTZQKUx41b59TiUSscyNVJIYMUqOfkd8-TVpdpIQKIgPAnCkyA8SQFPlew4KCaGoCJBO3JeJdEMSBMDTKM925L1not02uCygmYSe_9__D5ZwQu3E3NAKqPB2ByCbzJSR8U39wNNIuQu
  priority: 102
  providerName: Scholars Portal
Title Two case reports of a malignant germ cell tumor of ovary and a granulosa cell tumor: interest of tumoral immunochemistry in the identification and management
URI https://www.ncbi.nlm.nih.gov/pubmed/24982844
https://pubmed.ncbi.nlm.nih.gov/PMC4055855
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELbaDogF8aY8Kg8MLGnTOE4TNlTRFqQAQyt1i2zHhkptUvUB4sfwXznbaWlWFg_xJbLyXXz3OfdA6FYQSToAtqOoAILCBXd4CMRVgTGSJKLcTXW-c_wSDEb-85iOK4hucmFM0L7gk2Y2nTWzyYeJrZzPRGsTJ9Z6i7vgZICXS1tVVAUF3aHodvuluneBLeMDBCxqqTzTxQrbuk62G-m2e8A5gGn4fskYbS1QOTpyx9z0DtFB4SfiB7ueI1SR2THai4s_4SfoZ_iV4y6YIGxd6CXOFWY4Brf6Xce24D5subgrp1M8XM_yhZ5-_WSLb8yyFAT7YKPW03zJdmTusTkfBDuhpc0lWMKTziDRfbVsYzg8yTA4jdhm-KriyM889S-U5hSNeo_D7sApWi04gkRk5cCXGVAB3MNjAJ7vMkI7qcsEC1SYUl0iJyLC94QMgB4BjlQEwucd5lLphUq0yRmqZXkmLxCmbcZSojyeRsRX3A2jgHERsVQyysD41dHd5p0nc1tRIwEmopFKNFKJRioxSNXRuYViK7gBro46JZC2ArpadnkGlMhUzS6U5vLfd16hfb00e_5yjWqrxVregEey4g3D5GHsj9swxn7YMDr5C9Di5x8
link.rule.ids 230,315,730,783,787,867,888,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xSMAFsVNWHzhwSZvGcdpwQxW0LAEOReIW2Y4NldKk6gLiY_hXxnFa2ivXZBJZebbfPGcWgAtJFW0g2I5mEgWKkMIRTRSuGslI0ZAJNzH5ztFT0Hn179_Y2xKwaS5MEbQvRa-apf1q1vsoYisHfVmbxonVXqIWOhno5bLaMqzienX9OZFuN2BmuhfYQj4owcKazjNTrrBuKmW7oWm8h6oDtYbvL9DRjIMW4yPnCOd2CzZLT5Fc2xFtw5LKdmAtKv-F78JP9ysnLSQhYp3oEck14SRCx_rdRLeQNm66pKXSlHQn_Xxobj9_8uE34VmChm1kqUmaj_iczRUpTgiRKYx1cQmHcGdySExnLdsajvQygm4jsTm-ujz0K976F0yzB6-3N91WxymbLTiShnTs4NoMmET14XGEz3c5ZY3E5ZIHupkwUyQnpNL3pApQICGSTAbSFw3uMuU1tazTfVjJ8kwdAmF1zhOqPZGE1NfCbYYBFzLkieKMI_1V4HL6zeOBrakRoxYxSMUGqdggFRdIVeDAQjEznAJXgcYCSDMDUy978Q5Oo6Judjltjv795Dmsd7rRY_x49_RwDBtmmPY05gRWxsOJOkX_ZCzOitn4C9b657U
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELWgSBUXxE5ZfeDAJU1ax1m4oUIXoKWHVuotsh0bKrVJ1QXEx_CvjOO0tFeu8SSy8my_efZ4BqFbQSTxAWxLUQEChQtu8QCEqwIykiSk3In1fed2x2v23ecBHayV-sqC9gUflpPRuJwMP7LYyslY2Ms4MbvbroGTAV4utSexsrfRDsxZx1sT6mYRprqCgUnmAzIstFWa6JSFFZ0t2wl18T1QHqA3XHeDklY8tBkjuUY69X20l3uL-MH06gBtyeQQFdv5efgR-ul9pbgGRISNIz3DqcIMt8G5ftcRLrgBCy-uydEI9xbjdKqb3z7Z9BuzJAbDBjDVYpTO2JrNPc52CYEttHX2CLrQ0vdIdHUtUx4ODxMMriM293xVvvGXffUvoOYY9etPvVrTygsuWIKEZG7B_PSoAAVSZQCh6zBC_dhhgnkqiKlOlBMS4VaF9EAkAZpUeMLlPnOorAZKVMgJKiRpIs8QphXGYqKqPA6Jq7gThB7jImSxZJQBBZbQ3fKfRxOTVyMCPaKRijRSkUYqypAqoVMDxcpwCVwJ-RsgrQx0zuzNFhhKWe7sfOic__vNG1TsPtaj11bn5QLt6l6aDZlLVJhPF_IKXJQ5v84G4y8mOOjI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Two+Case+Reports+of+a+Malignant+Germ+Cell+Tumor+of+Ovary+and+a+Granulosa+Cell+Tumor%3A+Interest+of+Tumoral+Immunochemistry+in+the+Identification+and+Management&rft.jtitle=Frontiers+in+oncology&rft.au=Bouquet+de+Jolini%C3%83%C2%A8re%2C+J.&rft.au=Ben+Ali%2C+N.&rft.au=Fadhlaoui%2C+A.&rft.au=Dubuisson%2C+J.+B.&rft.date=2014-01-01&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=4&rft_id=info:doi/10.3389%2Ffonc.2014.00097&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fonc_2014_00097
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon